Regulation of autophagy by ATF4 in response to severe hypoxia T Rzymski, M Milani, L Pike, F Buffa, HR Mellor, L Winchester, I Pires, ... Oncogene 29 (31), 4424-4435, 2010 | 449 | 2010 |
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib M Milani, T Rzymski, HR Mellor, L Pike, A Bottini, D Generali, AL Harris Cancer research 69 (10), 4415-4423, 2009 | 336 | 2009 |
Safety of combining radiotherapy with immune-checkpoint inhibition WL Hwang, LRG Pike, TJ Royce, BA Mahal, JS Loeffler Nature reviews Clinical oncology 15 (8), 477-494, 2018 | 262 | 2018 |
The histone demethylase JMJD2B is regulated by estrogen receptor α and hypoxia, and is a key mediator of estrogen induced growth J Yang, AM Jubb, L Pike, FM Buffa, H Turley, D Baban, R Leek, KC Gatter, ... Cancer research 70 (16), 6456-6466, 2010 | 209 | 2010 |
A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells K Phadwal, J Alegre-Abarrategui, AS Watson, L Pike, S Anbalagan, ... autophagy 8 (4), 677-689, 2012 | 170 | 2012 |
Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival LRG Pike, DC Singleton, F Buffa, O Abramczyk, K Phadwal, JL Li, ... Biochemical Journal 449 (2), 389-400, 2013 | 169 | 2013 |
Multicenter evaluation of the tolerability of combined treatment with PD-1 and CTLA-4 immune checkpoint inhibitors and palliative radiation therapy A Bang, TJ Wilhite, LRG Pike, DN Cagney, AA Aizer, A Taylor, A Spektor, ... International Journal of Radiation Oncology* Biology* Physics 98 (2), 344-351, 2017 | 162 | 2017 |
The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors LRG Pike, A Bang, BA Mahal, A Taylor, M Krishnan, A Spektor, ... International Journal of Radiation Oncology* Biology* Physics 103 (1), 142-151, 2019 | 152 | 2019 |
The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress T Rzymski, A Petry, D Kračun, F Riess, L Pike, AL Harris, A Görlach Oncogene 31 (31), 3621-3634, 2012 | 95 | 2012 |
Radiation and PD-1 inhibition: favorable outcomes after brain-directed radiation LRG Pike, A Bang, P Ott, T Balboni, A Taylor, P Catalano, B Rawal, ... Radiotherapy and Oncology 124 (1), 98-103, 2017 | 60 | 2017 |
ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia LRG Pike, K Phadwal, AK Simon, AL Harris Molecular biology reports 39, 10811-10822, 2012 | 38 | 2012 |
Outcomes of HPV-associated squamous cell carcinoma of the head and neck: impact of race and socioeconomic status LRG Pike, TJ Royce, AR Mahal, DW Kim, WL Hwang, BA Mahal, ... Journal of the National Comprehensive Cancer Network 18 (2), 177-184, 2020 | 35 | 2020 |
Symptomatic necrosis with antibody-drug conjugates and concurrent stereotactic radiotherapy for brain metastases ES Lebow, LRG Pike, AD Seidman, N Moss, K Beal, Y Yu JAMA oncology 9 (12), 1729-1733, 2023 | 25 | 2023 |
Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis A Skakodub, H Walch, KR Tringale, J Eichholz, BS Imber, HN Vasudevan, ... Nature Communications 14 (1), 4980, 2023 | 21 | 2023 |
Conservative management of low‐risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database AR Mahal, S Butler, I Franco, V Muralidhar, D Larios, LRG Pike, SG Zhao, ... Cancer 125 (19), 3338-3346, 2019 | 21 | 2019 |
YU238259 is a novel inhibitor of homology-dependent DNA repair that exhibits synthetic lethality and radiosensitization in repair-deficient tumors GC Stachelek, E Peterson-Roth, Y Liu, RJ Fernandez III, LRG Pike, ... Molecular Cancer Research 13 (10), 1389-1397, 2015 | 21 | 2015 |
Fractionated proton radiation therapy and hearing preservation for vestibular schwannoma: preliminary analysis of a prospective phase 2 clinical trial A Saraf, LRG Pike, KH Franck, NK Horick, BY Yeap, BC Fullerton, ... Neurosurgery 90 (5), 506-514, 2022 | 17 | 2022 |
Trimodality therapy for HPV-positive oropharyngeal cancer: a population-based study: trimodality therapy for HPV+ OPC NN Sanford, WL Hwang, LRG Pike, AC Lam, TJ Royce, BA Mahal Oral oncology 98, 28-34, 2019 | 16 | 2019 |
31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 14 | 2016 |
Palliative radiation therapy for vertebral metastases and metastatic cord compression in patients treated with anti-PD-1 therapy MM Fareed, LRG Pike, A Bang, MA Huynh, A Taylor, A Spektor, MM Awad, ... Frontiers in Oncology 9, 199, 2019 | 13 | 2019 |